News & Events

ViPER Study Newsletter – February 2026

This issue contains an overview of Dose Modifications, as well as a few important updates and reminders for the study. We encourage you to review and share this newsletter locally with other study staff, as necessary. 

If you have any questions or ideas for topics that you think should be part of our next newsletter, please reach out to the study inbox.

URCC22053 Reminder: Required VIPER Screening Form in REDCap

URCC18007 Bupropion Study Closure Notification

URCC21038 DiRECT Accrual CLOSED!

URCC22053 | v3.0 Study Protocol Amendment Activation

URCC22053 Exciting Updates: TRIAD Live, Amendment Incoming, Q&A Session Scheduled

URCC19075 CIPN Study Closure

URCC19178 – Study Protocol Activation Version 4.0